Physician

James G Howard, MD

According to 2025 Medicare claims, James Howard, MD (NPI: 1033110119) practices ophthalmology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF UTAH, PLLC (NPI: 1396867214; TIN: 870525682) and primary practice location at 84107-6771.

Howard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 432 traditional Medicare patients, billed 49,254 HCPCS/CPT codes, and received $2,660,725 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 432 prescription claims across 135 beneficiaries totaling $16,746 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 51 records totaling $218,364. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,473 and ending at $16,746. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $1,903,450 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,904,696 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,915,488 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,856,779 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,859,985 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,783,500 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,649,437 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,557,003 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,053,003 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,660,725 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201550110,748$1,903,450
20164529,772$1,904,696
20174209,063$1,915,488
20184418,099$1,856,779
20194237,797$1,859,985
20203798,035$1,783,500
20213957,008$1,649,437
202237510,850$1,557,003
202342235,215$2,053,003
202443249,254$2,660,725

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$27K2015 Drug cost: $19,473 (USD; Tot_Drug_Cst)2016 Drug cost: $15,269 (USD; Tot_Drug_Cst)2017 Drug cost: $13,768 (USD; Tot_Drug_Cst)2018 Drug cost: $20,478 (USD; Tot_Drug_Cst)2019 Drug cost: $26,711 (USD; Tot_Drug_Cst)2020 Drug cost: $21,626 (USD; Tot_Drug_Cst)2021 Drug cost: $23,538 (USD; Tot_Drug_Cst)2022 Drug cost: $21,327 (USD; Tot_Drug_Cst)2023 Drug cost: $21,434 (USD; Tot_Drug_Cst)2024 Drug cost: $16,746 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015127442$19,473
2016114341$15,269
2017104308$13,768
2018123393$20,478
2019109376$26,711
2020110384$21,626
2021118368$23,538
2022126395$21,327
2023131385$21,434
2024135432$16,746

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system7777$105
67028Injection of drug into eye2261,173$101
92014Established patient complete exam of visual system343610$87
92134Imaging of retina4241,535$31
J2777Injection, faricimab-svoa, 0.1 mg8338,040$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1133,843$4,243
MoxifloxacinMoxifloxacin Hcl741,126$1,643
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14480$1,426
Ketorolac TromethamineKetorolac Tromethamine351,328$877
LatanoprostLatanoprost642,741$480

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$7,876Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.29$210,489Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James G. Howard, MD?

Tedicare shows public-source Medicare data for James G. Howard, MD (NPI 1033110119), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James G. Howard, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James G. Howard, MD?

James G. Howard, MD is linked to RETINA ASSOCIATES OF UTAH, PLLC (billing NPI 1396867214) in the available physician profile data.

Does James G. Howard, MD have Open Payments data?

James G. Howard, MD has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.